Cardiosave Rescue IABP, Part Number 0998-UC-0800-83
Published November 7, 2018 · Recall initiated: September 20, 2018
Summary
FDA records medical device Class I recall Z-0100-2019, published November 7, 2018 and initiated September 20, 2018. Recalling firm: Maquet Datascope Corp - Cardiac Assist Division; Status: Ongoing; Reported quantity: N/A; Lot: UDI - 10607567108407 All Serial Numbers. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a potential for interruption and/or inability to start therapy to the patient prior to or during use of Cardiosave IABP for users who are at altitudes above 3200 Ft.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Maquet Datascope Corp - Cardiac Assist Division
- Distributor
- US Nationwide; Internationally to 77 countries
- Lot
- UDI - 10607567108407 All Serial Numbers
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA60% Dark Chocolate Chips, packaged in poly-lined cardboard boxes, net wt. 30 lbs. The label is read in parts:November 7, 2018
- FDAEBI Osteogen Implantable Bone Growth Stimulator The OsteoGen Implantable Bone Growth Stimulator is indicatedNovember 7, 2018
- FDACS 100 Intra-Aortic Balloon Pump. It supports the heart's left ventricle by increasing coronary perfusion andSeptember 13, 2017
- FDACS 300 Intra-Aortic Balloon PumpAugust 2, 2017
- FDACS 100i Intra-Aortic Balloon PumpAugust 2, 2017
- FDACS 100 Intra-Aortic Balloon PumpAugust 2, 2017
Questions about this recall
Was Cardiosave Rescue IABP, Part Number 0998-UC-0800-83 recalled?
Yes. FDA published recall Z-0100-2019 on November 7, 2018. Reported hazard: There is a potential for interruption and/or inability to start therapy to the patient prior to or during use of Cardiosave IABP for users who are at altitudes above 3200 Ft.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release